Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Awards The Osteoporosis Canada Tim Murray Short-Term Training Awards These awards provide individuals with the opportunity to learn more about osteoporosis, advance existing research skills in osteoporosis and/or present their […]

Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. […]

Western Memorial Hospital, NL Western Memorial Hospital, NL Brookfield Chair In Fracture Prevention Funds New Fracture Liaison Service (Fls) Program In Corner Brook, Nl Brookfield Chair In Fracture Prevention Funds […]

Peace Arch Hospital, BC Peace Arch Hospital, BC Establishment of A FLS Training and Mentorship Program for the Peace Arch Hospital in B.C. Establishment of A FLS Training and Mentorship […]

Latest News CIHR Institute of Aging’s Knowledge Mobilization December 5, 2023 The Canadian Institutes of Health Research (CIHR) Institute of Aging’s (IA) Knowledge Mobilization webpage has shared links on information […]

This report provides a national overview on diagnosed osteoporosis, related fractures and the osteoporosis care gap among Canadians 40 years and older.  It reports on administrative data from the Canadian […]

LIVING WELL WITH OSTEOPOROSIS Managing osteoporosis to live a full and active life You Are Not Alone It is common to feel anxious about your health or lifestyle when diagnosed […]